Pharmacutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Biotechnol Prog. 2021 Jul;37(4):e3174. doi: 10.1002/btpr.3174. Epub 2021 May 26.
Stem cells can be used to repair dysfunctional and injured (or cancerous) tissues by delivering therapeutics. However, in comparison with other cells, it is harder to transfect drugs or genes into stem cells. Dendrimers have been considered as efficient vectors to deliver both genes and drugs to stem cells due to their unique properties including adjustable molecular weight and size, low toxicity, high loading capacity, and having multiple peripheral chemical agents which can be functionalized to improve deliverance efficiency. In this review, we discuss dendrimer-mediated drug and gene delivery to stem cells as cellular vehicles and the role of this strategy in treating a variety of disorders via regenerative medicine approaches.
干细胞可通过递送治疗剂来修复功能失调和受损(或癌变)的组织。然而,与其他细胞相比,将药物或基因转染到干细胞中更加困难。由于具有独特的性质,包括可调节的分子量和大小、低毒性、高载药能力以及具有多个可以功能化以提高递送效率的外围化学试剂,树枝状聚合物已被认为是将基因和药物递送到干细胞的有效载体。在这篇综述中,我们讨论了树枝状聚合物介导的药物和基因递送到干细胞作为细胞载体,以及通过再生医学方法治疗各种疾病的这种策略的作用。